The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...
Infants are among the most susceptible to respiratory complications from respiratory syncytial virus, or RSV. While they can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback